Answer
Licensed uses are limited to defined CFTR mutations and combinations, so genotype confirmation determines eligibility.
Sources for this answer
- Kalydeco 50 mg granules in sachetemc · SmPC Current selected SmPC · Version 5
- Kalydeco 75 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 12